The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells

Article English OPEN
Pickard, Mark R. ; Williams, Gwyn T. (2016)
  • Publisher: Impact Journals LLC
  • Journal: Oncotarget, volume 7, issue 9, pages 10,104-10,116 (eissn: 1949-2553)
  • Related identifiers: pmc: PMC4891107, doi: 10.18632/oncotarget.7173
  • Subject: apoptosis | breast cancer | GAS5 | lncRNA | Research Paper | oligonucleotide therapy | R1

Growth arrest-specific 5 (GAS5) lncRNA promotes apoptosis, and its expression is down-regulated in breast cancer. GAS5 lncRNA is a decoy of glucocorticoid/related receptors; a stem-loop sequence constitutes the GAS5 hormone response element mimic (HREM), which is essential for the regulation of breast cancer cell apoptosis. This preclinical study aimed to determine if the GAS5 HREM sequence alone promotes the apoptosis of breast cancer cells. Nucleofection of hormone-sensitive and –insensitive breast cancer cell lines with a GAS5 HREM DNA oligonucleotide increased both basal and ultraviolet-C-induced apoptosis, and decreased culture viability and clonogenic growth, similar to GAS5 lncRNA. The HREM oligonucleotide demonstrated similar sequence specificity to the native HREM for its functional activity and had no effect on endogenous GAS5 lncRNA levels. Certain chemically modified HREM oligonucleotides, notably DNA and RNA phosphorothioates, retained pro-apoptotic. activity. Crucially the HREM oligonucleotide could overcome apoptosis resistance secondary to deficient endogenous GAS5 lncRNA levels. Thus, the GAS5 lncRNA HREM sequence alone is sufficient to induce apoptosis in breast cancer cells, including triple-negative breast cancer cells. These findings further suggest that emerging knowledge of structure/function relationships in the field of lncRNA biology can be exploited for the development of entirely novel, oligonucleotide mimic-based, cancer therapies.
  • References (29)
    29 references, page 1 of 3

    1. Hangauer MJ, Vaughn IW, McManus MT. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS genetics. 2013; 9:e1003569

    2. Mattick JS, Rinn JL. Discovery and annotation of long noncoding RNAs. Nature structural & molecular biology. 2015; 22: 5-7.

    3. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Molecular cancer. 2011; 10: 38.

    4. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013; 193: 651-669.

    5. Yang L, Froberg JE, Lee JT. Long noncoding RNAs: fresh perspectives into the RNA world. Trends in biochemical sciences. 2014; 39: 35-43.

    6. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA biology. 2012; 9: 703-719.

    7. Cheetham SW, Gruhl F, Mattick JS, Dinger ME. Long noncoding RNAs and the genetics of cancer. British journal of cancer. 2013; 108: 2419-2425.

    8. Smith CM, Steitz JA. Classification of gas5 as a multismall-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Molecular and cellular biology. 1998; 18: 6897-6909.

    9. Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J. Human box C/D snoRNAs with miRNA like functions: Expanding the range of regulatory RNAs. Nucleic acids research. 2011; 39: 675-686.

    10. He X, Chen X, Zhang X, Duan X, Pan T, Hu Q, Zhang Y, Zhong F, Liu J, Zhang H, Luo J, Wu K, Peng G, Luo H, Zhang L et al. An LncRNA (GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by site-specifi - cally recruiting MLL/COMPASS-like complexes. Nucleic acids research. 2015; 43: 3712-3725.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark